Table 3.

sICH and bleeding events of patients

Outcome	Aspirin, n (%)	DAPT, n (%)	Intravenous t-PA, n (%)
sICH (per ECASS II)			8 (2.1)
Bleeding (GUSTO）
Serious	1 (0.4)	0 (0.0)
Moderate	1 (0.4)	0 (0.0)
Minor	0 (0.0)	2 (0.9)
Any bleeding	2 (0.9)	1 (0.5)

DAPT, dual antiplatelet therapy; ECASS II, European Co-operative Acute Stroke Study-II; GUSTO, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; sICH, symptomatic intracranial haemorrhage; t-PA, recombinant tissue plasminogen activator.